Literature DB >> 3489042

Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogeneic T lymphocytes.

D Rubinstein, A K Roska, P E Lipsky.   

Abstract

Guinea pig liver sinusoidal lining cells (LSLC), a mixture of Kupffer cells (KC) and sinusoidal endothelial cells (EC), were examined for their capacity to function as antigen-presenting cells (APC). LSLC were extremely poor stimulators of freshly isolated allogeneic T lymphocytes even though a large number of them expressed class II major histocompatibility complex (MHC) antigens (Ia). This deficiency could not be explained by a lack of soluble factor production by LSLC, because an interleukin 1-containing macrophage (M phi) supernatant could not restore the capacity of LSLC to stimulate allogeneic T cells. Moreover, LSLC were able to promote mitogen-induced proliferation of accessory cell-depleted T lymphocytes. No evidence of suppression was apparent in experiments in which LSLC were added to cultures of T cells stimulated by allogeneic peritoneal exudate M phi (PEM). The Ia expressed by LSLC was functional because they were able to stimulate an alloreactive T cell line. When LSLC were mixed and co-cultured with either PEM syngeneic to the responding lymphocytes or Ia-negative fibroblasts, the allostimulatory ability of LSLC was greatly augmented. In contrast, the addition of mitogen-activated T cell supernatants had only a minimal effect on the capacity of LSLC to stimulate allogeneic T cells. The data suggest that LSLC lack a biologic property that is necessary for recognition of class II MHC determinants by fresh but not primed allogeneic T cells and that is not required to support T cell activation induced by nonspecific mitogenic lectins. These findings may be important in understanding the reason that antigen introduced into the portal blood appears not to initiate an immune response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489042

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 2.  Liver Sinusoidal Endothelial Cell: An Update.

Authors:  Laurie D DeLeve; Ana C Maretti-Mira
Journal:  Semin Liver Dis       Date:  2017-12-22       Impact factor: 6.115

3.  Phenotypic heterogeneity of vascular endothelial cells in the human kidney.

Authors:  T Kinjo; M Takashi; K Miyake; H Nagura
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

4.  Purified human NK cells do not function as accessory cells in T-cell proliferative responses.

Authors:  O Silvennoinen
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

5.  Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.

Authors:  L Leifeld; C Trautwein; F L Dumoulin; M P Manns; T Sauerbruch; U Spengler
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 6.  Mechanisms of drug-induced liver injury.

Authors:  Michael P Holt; Cynthia Ju
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

7.  IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules.

Authors:  P A Knolle; A Uhrig; S Hegenbarth; E Löser; E Schmitt; G Gerken; A W Lohse
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

8.  Human osteoblast-like cells expressing MHC class II determinants stimulate allogeneic and autologous peripheral blood mononuclear cells and function as antigen-presenting cells.

Authors:  H Skjødt; T Møller; S F Freiesleben
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

9.  Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice.

Authors:  Qizhen Shi; Christopher V Carman; Yingyu Chen; Peter T Sage; Feng Xue; Xin M Liang; Gary E Gilbert
Journal:  Blood Adv       Date:  2020-05-26

10.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.